Scientists: ‘Positive’ Results In 1st Human Trial Of Experimental Ebola Vaccine

12

Categories:

UNITED STATES, Nov 27 – The first human trial of an experimental Ebola vaccine has produced promising results, U.S. scientists said, raising hopes that protection from the deadly disease may be on the horizon. All 20 healthy adults who received the vaccine in a trial run by researchers from the National Institutes of Health in Maryland produced an immune response and developed anti-Ebola antibodies, the NIH said Wednesday.

None suffered serious side effects, although two people developed a brief fever within a day of vaccination. The vaccine is being developed by the NIH’s National Institute of Allergy and Infectious Diseases and British pharmaceutical giant GlaxoSmithKline. The process has been fast-tracked in light of the current catastrophic Ebola outbreak in West Africa, which has claimed more than 5,000 lives.

“Based on these positive results from the first human trial of this candidate vaccine, we are continuing our accelerated plan for larger trials to determine if the vaccine is efficacious in preventing Ebola infection,” said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. In this trial, genetic material from two strains of the Ebola virus, Sudan and Zaire, was delivered using a chimpanzee cold virus that does not harm humans. The vaccine does not contain the Ebola virus and cannot cause a person to be infected with Ebola, the NIH said. The current outbreak involves the Zaire strain.

0
like
0
love
0
haha
0
wow
0
sad
0
angry
  • Amazing Fireworks Display! https://t.co/kGn3mVWBPB Jul 21, 2018
  • Dr Mahathir: PAS, BN Are ‘Siblings ‘ https://t.co/0dWhTvqOnI Jul 21, 2018
  • Govt Expects To Hit 2018 5.5%-6.0% GDP Target https://t.co/JRVMIcdx6B Jul 21, 2018

error: Content Is Protected !